Outcomes of Hematopoietic Stem Cell Transplant in Transfusion Dependent Thalassemia: A Single Center Experience from Low Middle Income Country | Synapse
March 3, 2026
Outcomes of Hematopoietic Stem Cell Transplant in Transfusion Dependent Thalassemia: A Single Center Experience from Low Middle Income Country
Key Points
Transplant outcomes show a significant improvement in hemoglobin levels in patients with thalassemia.
Around 80% of patients achieved transfusion independence within two years after the transplant.
Observational analysis at a single center demonstrates the feasibility and effectiveness of stem cell transplants.
Highlights the need for more accessible transplant options in low-middle income countries.